JURNISTA

This brand name is authorized in Australia, Germany, Estonia, Spain, Singapore, South Africa

Active ingredients

The drug JURNISTA contains one active pharmaceutical ingredient (API):

1 Hydromorphone
UNII L960UP2KRW - HYDROMORPHONE HYDROCHLORIDE

Hydromorphone is an agonist of mu receptors. The pharmacological actions of hydromorphone and morphine do not differ significantly. Hydromorphone and related opioids produce their major effects on the central nervous system and bowel. Hydromorphone is indicated for the relief of severe pain in cancer.

Read about Hydromorphone

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
JURNISTA Prolonged-release tablet Marketing Authorisation Holder MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N02AA03 Hydromorphone N Nervous system → N02 Analgesics → N02A Opioids → N02AA Natural opium alkaloids
Discover more medicines within N02AA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 12473L, 12482Y, 12496Q, 12535R, 12543E, 9299K, 9406C, 9407D, 9408E, 9409F
Country: DE Bundesinstitut fรผr Arzneimittel und Medizinprodukte Identifier(s): 01909126, 01909132, 01909149, 01909161, 04552498, 04580193, 04608394, 04608402, 04608419, 04608425, 04608431, 04608448, 04608454, 04608460, 06319576, 06320013, 06320088, 08769757, 08769763, 08769881, 08770743, 08771145, 08771961, 08771978, 10122365, 10122371, 10122388, 10122394, 10122402, 10122419, 10122425, 10122431, 10122448, 10122454, 10122460, 10122477, 10122483, 10122508, 10319926, 10319955, 10319961, 10319978, 10319984, 10319990, 10320007, 10320036, 10320042, 10764738, 10764750, 10764773, 10822387, 10822393, 11653596, 11653604, 11653610, 11653627, 11653633, 11653656, 11653662, 11653679, 12484575, 12484581, 13890461, 15392767, 15392773, 16358459, 16358465, 16697552, 16792693, 17888372
Country: EE Ravimiamet Identifier(s): 1226359, 1226371, 1226382, 1226393, 1226405, 1226416, 1226427, 1226438, 1226449, 1226450, 1226461, 1226472, 1226483, 1226618, 1226629, 1226630, 1226641, 1226652, 1226663, 1226674, 1226685, 1226696, 1226708, 1226719, 1226720, 1226731, 1226742, 1226753, 1226764, 1226775, 1226786, 1226797, 1226809, 1226810, 1226821, 1226832, 1226843, 1226854, 1226865, 1226876, 1226887, 1226898, 1226900, 1226911, 1226922, 1226933, 1226944, 1226955, 1273957, 1273968, 1273979, 1273980, 1273991, 1274004, 1274015, 1274026, 1274037, 1274048, 1274059, 1274060
Country: ES Centro de informaciรณn online de medicamentos de la AEMPS Identifier(s): 68018, 68019, 68020, 69710
Country: SG Health Sciences Authority Identifier(s): 13616P
Country: ZA Health Products Regulatory Authority Identifier(s): 41/2.9/1130, 41/2.9/1131, 41/2.9/1132, 41/2.9/1133, 41/2.9/1136

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.